Wagner Ernst
Ludwig-Maximilians-Universität, Professor and Chairman of Pharmaceutical Biology-Biotechnology, Department of Pharmacy, Butenandtstrasse 5-13, D-81377, Munich, Germany.
Expert Opin Biol Ther. 2007 May;7(5):587-93. doi: 10.1517/14712598.7.5.587.
Programmed nanoscaled systems are emerging that may be very useful for tumor-targeted drug delivery: novel nanoparticles are pre-programmed to alter their structure and properties during the drug delivery process to make them most effective for the different extra- and intracellular delivery steps. Programming is effected by the incorporation of molecular sensors that are able to respond to physical or biological stimuli, including changes in pH, redox potential or enzymes. Tumor-targeting principles include systemic passive targeting and active receptor targeting. Physical forces (e.g., electric or magnetic fields, ultrasound, hyperthermia or light) may contribute to focusing and triggered activation of nanosystems. Biological drugs delivered with programmed nanosystems also include plasmid DNA, small interfering RNA and related therapeutic nucleic acids formulated as 'synthetic viruses'.
新型纳米颗粒经过预编程,可在给药过程中改变其结构和性质,从而使其在不同的细胞外和细胞内给药步骤中发挥最大功效。通过纳入能够对物理或生物刺激(包括pH值、氧化还原电位或酶的变化)作出反应的分子传感器来实现编程。肿瘤靶向原理包括全身被动靶向和主动受体靶向。物理力(如电场或磁场、超声波、热疗或光)可能有助于纳米系统的聚焦和触发激活。用程序化纳米系统递送的生物药物还包括质粒DNA、小干扰RNA和配制成“合成病毒”的相关治疗性核酸。